GR3030816T3 - Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists - Google Patents
Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonistsInfo
- Publication number
- GR3030816T3 GR3030816T3 GR990401904T GR990401904T GR3030816T3 GR 3030816 T3 GR3030816 T3 GR 3030816T3 GR 990401904 T GR990401904 T GR 990401904T GR 990401904 T GR990401904 T GR 990401904T GR 3030816 T3 GR3030816 T3 GR 3030816T3
- Authority
- GR
- Greece
- Prior art keywords
- receptor antagonists
- pct
- hexahydroazepinones
- benzazepinones
- tetrahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9764093A | 1993-07-26 | 1993-07-26 | |
| PCT/IB1994/000111 WO1995003281A1 (en) | 1993-07-26 | 1994-05-19 | Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3030816T3 true GR3030816T3 (en) | 1999-11-30 |
Family
ID=22264420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR990401904T GR3030816T3 (en) | 1993-07-26 | 1999-07-20 | Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5618811A (el) |
| EP (1) | EP0711283B1 (el) |
| JP (1) | JP2862675B2 (el) |
| AT (1) | ATE181323T1 (el) |
| AU (1) | AU6686694A (el) |
| CA (1) | CA2168131C (el) |
| DE (1) | DE69419157T2 (el) |
| DK (1) | DK0711283T3 (el) |
| ES (1) | ES2132401T3 (el) |
| FI (4) | FI943499A (el) |
| GR (1) | GR3030816T3 (el) |
| IL (1) | IL110349A0 (el) |
| WO (1) | WO1995003281A1 (el) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063794A (en) | 1996-10-11 | 2000-05-16 | Cor Therapeutics Inc. | Selective factor Xa inhibitors |
| US6194435B1 (en) | 1996-10-11 | 2001-02-27 | Cor Therapeutics, Inc. | Lactams as selective factor Xa inhibitors |
| US6262047B1 (en) | 1996-10-11 | 2001-07-17 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6369080B2 (en) | 1996-10-11 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| EP0975625A1 (en) | 1997-04-14 | 2000-02-02 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
| JP2001523226A (ja) | 1997-04-14 | 2001-11-20 | シーオーアール セラピューティクス インコーポレイテッド | 選択的Ｘａ因子阻害剤 |
| WO1998046627A1 (en) | 1997-04-14 | 1998-10-22 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
| US6218382B1 (en) | 1997-08-11 | 2001-04-17 | Cor Therapeutics, Inc | Selective factor Xa inhibitors |
| US6333321B1 (en) | 1997-08-11 | 2001-12-25 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| EP1156803A4 (en) * | 1999-02-09 | 2004-03-17 | Bristol Myers Squibb Co | FXA LACTAM INHIBITORS AND METHOD |
| US6344450B1 (en) | 1999-02-09 | 2002-02-05 | Bristol-Myers Squibb Company | Lactam compounds and their use as inhibitors of serine proteases and method |
| US6319915B1 (en) * | 1999-08-27 | 2001-11-20 | Pfizer Inc. | Benzazepine derivatives as inhibitors of hyperproliferation diseases |
| US6511973B2 (en) | 2000-08-02 | 2003-01-28 | Bristol-Myers Squibb Co. | Lactam inhibitors of FXa and method |
| ES2423412T3 (es) * | 2005-06-06 | 2013-09-20 | The Board Of Trustees Of The University Of Illinois | Composiciones y métodos para tratar los trastornos del sueño |
| UA105182C2 (ru) | 2008-07-03 | 2014-04-25 | Ньюрексон, Інк. | Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04210967A (ja) * | 1989-12-28 | 1992-08-03 | Yoshitomi Pharmaceut Ind Ltd | ２−ベンズアゼピン化合物 |
| US5206234A (en) * | 1990-10-22 | 1993-04-27 | Merck & Co., Inc. | Benzolactam analogs as antagonists of cck |
| TW213901B (el) * | 1992-01-27 | 1993-10-01 | Pfizer |
-
1994
- 1994-05-19 JP JP7505034A patent/JP2862675B2/ja not_active Expired - Lifetime
- 1994-05-19 DK DK94914525T patent/DK0711283T3/da active
- 1994-05-19 DE DE69419157T patent/DE69419157T2/de not_active Expired - Fee Related
- 1994-05-19 AT AT94914525T patent/ATE181323T1/de not_active IP Right Cessation
- 1994-05-19 AU AU66866/94A patent/AU6686694A/en not_active Abandoned
- 1994-05-19 CA CA002168131A patent/CA2168131C/en not_active Expired - Fee Related
- 1994-05-19 US US08/586,685 patent/US5618811A/en not_active Expired - Fee Related
- 1994-05-19 EP EP94914525A patent/EP0711283B1/en not_active Expired - Lifetime
- 1994-05-19 WO PCT/IB1994/000111 patent/WO1995003281A1/en active IP Right Grant
- 1994-05-19 ES ES94914525T patent/ES2132401T3/es not_active Expired - Lifetime
- 1994-07-18 IL IL11034994A patent/IL110349A0/xx unknown
- 1994-07-25 FI FI943499A patent/FI943499A/fi unknown
-
1999
- 1999-07-20 GR GR990401904T patent/GR3030816T3/el unknown
- 1999-09-23 FI FI992037A patent/FI19992037A/fi unknown
- 1999-09-23 FI FI992038A patent/FI19992038A/fi unknown
- 1999-09-23 FI FI992039A patent/FI19992039A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2168131A1 (en) | 1995-02-02 |
| CA2168131C (en) | 1998-10-06 |
| EP0711283A1 (en) | 1996-05-15 |
| US5618811A (en) | 1997-04-08 |
| EP0711283B1 (en) | 1999-06-16 |
| FI19992037A (fi) | 1999-09-23 |
| WO1995003281A1 (en) | 1995-02-02 |
| JP2862675B2 (ja) | 1999-03-03 |
| ES2132401T3 (es) | 1999-08-16 |
| FI943499A0 (fi) | 1994-07-25 |
| FI19992038A (fi) | 1999-09-23 |
| DK0711283T3 (da) | 1999-11-22 |
| DE69419157D1 (de) | 1999-07-22 |
| ATE181323T1 (de) | 1999-07-15 |
| DE69419157T2 (de) | 1999-10-14 |
| FI943499A (fi) | 1995-01-27 |
| AU6686694A (en) | 1995-02-20 |
| IL110349A0 (en) | 1994-10-21 |
| JPH08508039A (ja) | 1996-08-27 |
| FI19992039A (fi) | 1999-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3030816T3 (en) | Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists | |
| ZA945817B (en) | Tropyl 7-azaindol-3-ylcarboxyamides | |
| IL102208A0 (en) | Azanorbornane derivatives | |
| SG55184A1 (en) | New imidazopyridines | |
| GR3036813T3 (en) | Novel n-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1h-benzo[b][1,4]diazepin-3-yl)-acetamides | |
| ZA965235B (en) | Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders | |
| DK0561941T3 (da) | N-Substituerede lactamer anvendelige som cholecystokinin-antagonister | |
| MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
| AU1884595A (en) | Novel acyclic and cyclic amides as neurotransmitter release enhancers | |
| GR3030626T3 (en) | 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists | |
| HUT67963A (en) | Benzodiazepine derivatives as cck-receptor antagonits and pharmaceutical compositions containing them | |
| GR3021314T3 (en) | N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders. | |
| HU9502067D0 (en) | N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders | |
| GR3027609T3 (en) | Carbamate derivatives and their use in medicine. | |
| GB9308431D0 (en) | Chemical compounds | |
| DK0691846T3 (da) | Imidazoquinoxalinoner til behandling af sygdomme i centralnervesystemet |